Insider Trading activities of Chemokine Therapeutics Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Chemokine Therapeutics Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Chemokine Therapeutics Corp since year 2005. Table 2 shows the detailed insider transactions of Chemokine Therapeutics Corp since 2005. The reporting company's ticker symbol is CHKT. The reporting company's CIK number is 1092959.
The total value of stock buying since 2005 is $503,329.
The total value of stock sales since 2005 is $4,269.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Chemokine Therapeutics Corp (CHKT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2009-01 605,400 $7,626 0 $0 0 $0
2008-08 1,445,000 $104,204 45,650 $4,269 0 $0
2008-06 746,666 $111,999 0 $0 0 $0
2008-04 100,000 $17,000 0 $0 0 $0
2008-02 1,312,500 $262,500 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Chemokine Therapeutics Corp insiders (CHKT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-01-15 Salari Hassan (10% Owner) Buy 256,900 .01 2,569
2009-01-12 Salari Hassan (10% Owner) Buy 34,000 .01 340
2009-01-09 Salari Hassan (10% Owner) Buy 314,500 .02 4,717
2008-08-27 Salari Hassan (10% Owner) Buy 1,390,000 .07 100,079
2008-08-25 Evans Donald Rm (V.P. Corporate Communications) Sale 44,200 .09 4,110
2008-08-22 Evans Donald Rm (V.P. Corporate Communications) Buy 55,000 .08 4,125
2008-08-22 Evans Donald Rm (V.P. Corporate Communications) Sale 1,450 .11 159
2008-06-13 Kowalchuk George M (Director) Buy 666,666 .15 99,999
2008-06-13 Salari Hassan (Chief Scientific Officer) Buy 80,000 .15 12,000
2008-04-16 Salari Hassan (Chief Scientific Officer) Buy 50,000 .18 9,000
2008-04-10 Salari Hassan (Pres./Chief Scientific Officer) Buy 50,000 .16 8,000
2008-02-07 Bahadori Reza (Director) Buy 300,000 .20 60,000
2008-02-07 Byrd Bernard C Ii (Director) Buy 300,000 .20 60,000
2008-02-07 Kuhn Brian (Director) Buy 300,000 .20 60,000
2008-02-07 Korz Walter (Vice President, Drug Dev.) Buy 50,000 .20 10,000
2008-02-07 Salari Hassan (Pres./Chief Scientific Officer) Buy 312,500 .20 62,500
2008-02-07 Jaffer Bashir (Chief Financial Officer) Buy 50,000 .20 10,000

Insider trading activities including stock purchases, stock sales, and option exercises of CHKT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Chemokine Therapeutics Corp (symbol CHKT, CIK number 1092959) see the Securities and Exchange Commission (SEC) website.